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Abstract Neurotrophins support neuronal survival, develop-
ment, and plasticity through processes requiring gene expression.
We studied how vgf target gene transcription is mediated by a
critical promoter region containing E-box, CCAAT and cAMP
response element (CRE) sites. The p300 acetylase was present in
two distinct protein complexes bound to this region. One
complex, containing HEB (ubiquitous basic helix^loop^helix
(bHLH)), bound the promoter in non-neuronal cells and was
involved in repressing vgf expression. Neurotrophin-dependent
transcription was mediated by the second complex, specific for
neuronal cells, which included CRE binding protein and MASH1
(neuro-specific bHLH), bound the CCAAT motif, and was target
of neurotrophin signalling. The interaction, mediated by p300, of
different transcription factors may add specificity to the
neurotrophin response. ß 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Neurotrophins (nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin 3 (NT3), NT4/5
and NT6) control neuronal survival, di¡erentiation and plas-
ticity, and are involved in learning and memory [1^3]. They
use two types of receptors: TrkA^C tyrosine kinases, speci¢c
for di¡erent neurotrophins, and p75NTR, which is bound by
all and lacks kinase activity. p75NTR signals survival or apo-
ptosis via JNK, p53, nuclear factor-UB and other intermedi-
ates, whereas Trk family receptors promote di¡erentiation
and survival through Ras/mitogen-activated protein kinase
(MAPK), PI3K/AKT, and PLC-Q signalling cascades [1,2].
cAMP response element binding proteins (CREBs) are critical
mediators of neurotrophin-dependent gene expression and of
transcription of ‘memory genes’ during LTP [4,5]. Neurotro-
phins cause sustained activation of MAPKs (ERK/MAPKs)
through cooperation of Ras and cAMP-dependent protein ki-
nase signalling pathways [6]. This switches on Rsk2, a kinase
that phosphorylates CREB bound to the CRE [7,8]. Since
CREB is ubiquitous and responds to a variety of di¡erent
stimuli, other factors must be involved in conferring transcrip-
tional speci¢city to neurotrophin signals. We addressed this
question by studying vgf transcription, which is developmen-
tally regulated, modulated by electrical activity, and selec-
tively induced by NGF, BDNF and NT3 [9^11]. Vgf encodes
a precursor protein that undergoes regulated secretion and
cleavage into peptides, regulating the body energy balance
[12]. Tissue speci¢city and neurotrophin responsiveness in-
volve a tripartite promoter region of about 110 bp (from
3180 to 370) that includes E-box (CAGGTG), CCAAT
(TCCAATCATTGGA) and CRE (CATTGACGTCAATG)
consensus sequences [10,11]. The E-box was shown to have
a dual role as repressor and weak enhancer in non-neuronal
and neuronal cells, respectively [13], and to bind HEB, a
member of the E protein family (HEB, E2A, E2-2) of ubiq-
uitous basic helix^loop^helix (bHLH) transcription factors
[14]. The vgf CRE, by itself, mediates the weak transcriptional
response elicited by cAMP in PC12 cells, but it is not su⁄-
cient for the stronger activation by NGF, which requires the
CCAAT site as well [10,11]. CREB and the CREB family
proteins ATF1 and ATF2 were shown to bind the vgf CRE
in in vitro binding experiments, whereas the CCAAT bound
factors were not characterized [10]. By using as probe the
whole 110 bp region, rather than short sequences containing
a single protein binding site, we showed the presence of two
protein complexes interacting with the vgf promoter in vitro.
The C complex, neuro-speci¢c, strongly binds the CCAAT
sequence, while the E^CRE complex, ubiquitous, interacts
with E-box and CRE sites [13].
In this work, we have investigated which factors are present
in the two complexes and what is their function. The p300
acetylase was present in both complexes, which appeared to
have opposite functions in transcriptional regulation. The E^
CRE complex, which involved HEB, appeared to have a role
in tissue-speci¢c repression, whereas the C complex, which
included CREB and the neuro-speci¢c bHLH MASH1, ap-
peared to mediate neurotrophin responsiveness.
2. Materials and methods
2.1. Cell culture and transfections
Cells were cultured as previously described [11,13]. NIH3T3 cells
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(3U105 cells/35 mm plate) and PC12 cells (3U106 cells) were trans-
fected overnight by Lipofectamine (Gibco BRL). Transfections con-
tained 0.5 Wg reporter plasmid, the indicated amounts of expression
vector DNAs and 0.2 Wg pRSV-Lgal as internal standard; vector
DNA was added to keep the DNA amount constant. Following trans-
fection, NIH3T3 cells were cultured for 24^30 h and PC12 cells were
subcultured in two dishes, one of which was treated with 100 ng/ml
NGF for 36 h. Cells were lysed and processed for CAT activity as
described [13]. Reported CAT values, normalized to L-galactosidase
activity of the standard, are relative to those observed with the re-
porter alone. Each value represents the average, and standard devia-
tion of the mean, of at least three independent transfections.
For HEB detection, nuclear proteins were extracted from a 100 mm
plate of pCSHEB-transfected NIH3T3 cells. Western blots were
probed with anti-HEB (Santa Cruz, 1/100), followed by protein A^
horseradish peroxidase and ECL detection (Amersham).
For di¡erentiation analysis, PC12 cells (1.5U106 cells) were trans-
fected with 1 Wg pRSV-Lgal and the indicated amounts of E1A dl922^
947 DNA. After 24 h cells were resuspended in 1% serum, replated,
stimulated with 100 ng/ml NGF, grown for 3^4 days, ¢xed (2% form-
aldehyde^0.2% glutaraldehyde in 0.1 M phosphate bu¡er) and stained
for L-galactosidase with X-gal solution. Cells were counted as di¡er-
entiated if the length of neurites was at least 1.5 times the cell body
diameter.
2.2. Plasmid construction
3179vgfCAT was previously described [13]; p4ECvgfCAT was gen-
erated by polymerization and cloning of a 3178 to 3132 vgf promoter
oligonucleotide into pLBKv44CAT XbaI^BglII sites [15]. To con-
struct pCSHEB, the HEB sequence was PCR-ampli¢ed with oligonu-
cleotides 5P-GAGAGAGGATCCATGAATCCCCAGCAACAACG-
C-3P and 5P-GCCTAGCTCGATACAATAAACGCCAT-3P and
inserted between pGEX-2TK BamHI^SmaI sites. The GST-HEB se-
quence was then ampli¢ed with primers 5P-GAGAGAATCGATGTC-
CCCTATACTAGGTTA-3P and 5P-CCTACTGAGAATTCTGGAA-
CTGGC-3P and cloned in pCS (from D. Turner) ClaI^SnaBI sites.
For GST-vbHEB construction, the sequence encoding HEB last 92
amino acids was ampli¢ed with 5P-GAACGCTTAGGATCCCGG-
GATATTAA-3P and 5P-CCTACTGAGAATTCTGGAACTGGC-3P
oligonucleotides and cloned into pGEX-2T BamHI^EcoRI sites. Con-
structs were veri¢ed by sequencing. pRSVMASH1 was by D. Ander-
son, the E1A12S mutant dl922^947 by A. Felsani.
2.3. Electrophoretic mobility shift assays (EMSAs)
Gel shifts were performed with a 3183 to 365 vgf probe, as de-
scribed [13]. The CCAAT competitor oligonucleotide sequence is 5P-
TACTGCGTCACATCAGGCCGGGAGCGACGCTTATCCTCCA-
ATCATTG-3P [13]. The following antibodies were added before the
probe: KCBP [16], KHEB (Santa Cruz), KMASH1 [17], KCREB (New
England Biolabs), Kphospho-CREB (Upstate Biotechnology) rabbit
antisera (1 Wl each); AC238, Rw128 and Rw144 p300 monoclonals
[18] ; pre-immune sera as control. AC238 (0.5 Wl) was used as ascite
£uid, Rw128 and Rw144 (5 Wl each) as culture supernatants. Rw144
does not recognize CBP under the diluted conditions it was employed;
AC238 recognizes both p300 and CBP [18]. GST and GST-vbHEB
proteins were a⁄nity-puri¢ed on glutathione agarose beads and
checked by SDS^PAGE.
3. Results
3.1. Role of the C complex in NGF-dependent transcription
Phospho-CREB is a critical mediator of neurotrophin-de-
pendent transcription, and is rapidly detected following NGF
treatment of PC12 cells [5,7,8]. To clarify which of the two
complexes bound to vgf promoter was involved in neurotro-
phin responsiveness, we studied by gel shift how CREB or
phospho-CREB antibodies a¡ected DNA binding in extracts
of PC12 cells treated with NGF for di¡erent time periods. The
CREB antibody recognizes both phosphorylated and non-
phosphorylated form of CREB, whereas the phospho-CREB
antibody is speci¢c for phosphorylation on serine 133. Sur-
prisingly, the CREB antibody inhibited C complex binding in
all samples including the NGF untreated control. The phos-
pho-CREB antibody had an impact on this complex that was
stronger with increasing NGF incubation time (Fig. 1). This
shows that CREB interacts with the vgf promoter within the
Fig. 1. NGF-induced CREB phosphorylation in the C complex. EMSA on nuclear extracts of PC12 cells treated with NGF (0^120 min). Bind-
ing reactions contained extract and vgf promoter probe alone (lanes 2, 6, 10, 14) or also included CCAAT competitor oligonucleotide (100-fold
excess; lanes 3, 7, 11), anti-CREB (lanes 4, 8, 12) or anti-phospho-CREB serum (lanes 5, 9, 13, 15); lane 1 has probe and anti-phospho-
CREB, but no extract.
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CCAAT bound complex, pointing to this complex as the me-
diator of NGF-dependent transcription. On the contrary, the
E^CRE complex was una¡ected, indicating that CREB was
either not present or inaccessible to the antibodies; possibly a
di¡erent CREB family protein is involved. These data, ob-
tained with a complex promoter sequence, add information
to results obtained with a single binding site, such as CRE.
The vgf CRE, alone, binds perfectly well CREB [10], while
this transcription factor appeared to be preferentially associ-
ated to the CCAAT, in the context of the vgf promoter.
3.2. Tissue speci¢city: MASH1
Due to its tissue speci¢city, we expected that the promoter
was bound by neuro-speci¢c proteins in PC12 cells. Tissue-
speci¢c bHLH factors, functioning in cell di¡erentiation as
heterodimers with E proteins, represented natural candidates,
since the HEB E protein was shown to bind the vgf promoter
E-box [13,14]. On the other hand, the E-box bound complex is
not tissue-speci¢c, while the CCAAT bound complex is [13].
To ¢nd out whether HLH proteins were present, we utilized
GST-vbHEB, a chimera between GST and the HLH dimeri-
zation domain of HEB, as a DNA binding inhibitor in gel
shift assays with PC12 cell extracts. GST-vbHEB has the
potential to dimerize with a variety of bHLH proteins [15] ;
DNA binding of the dimers is prevented since GST-vbHEB
lacks the basic region and two basic regions are required for
DNA binding [14]. As a matter of fact, it was able to inhibit
in vitro binding of puri¢ed HEB to the E-box (not shown).
GST-vbHEB a¡ected the HEB containing E^CRE complex,
as expected (Fig. 2). Surprisingly, and more e⁄ciently, it in-
hibited binding of the C complex (Fig. 2A, lanes 2^5), sug-
gesting that a protein capable of interacting with the HLH
domain of HEB was involved. Such a protein was identi¢ed as
the neuro-speci¢c bHLH MASH1, which is present in PC12
cells, heterodimerizes with HEB, and has a role in neuronal
di¡erentiation [14,17,19]. A MASH1 antiserum (Fig. 2B) pre-
vented binding of the C complex, which was una¡ected by
control antiserum or by antibodies against a number of tran-
scription factors (not shown).
3.3. Presence of p300 in two vgf promoter complexes
CBP and p300 are highly related proteins that interact with
sequence-speci¢c transcription factors to promote assembly of
transcription initiation complexes. They are able to bind
CREB as well as ubiquitous or tissue-speci¢c bHLH proteins
[18,20]. In order to assess the presence of p300/CBP, we in-
vestigated whether antibodies speci¢c for these coactivators
a¡ected complex formation in gel shift assays with a vgf pro-
moter probe and PC12 (Fig. 3A) or NIH3T3 (Fig. 3B) cell
nuclear extracts. Fig. 3A (lanes 2^4) illustrates that the lower
mobility component of the C complex doublet was a¡ected by
all p300 antibodies, suggesting that p300 participates in the
CCAAT bound complex. The ubiquitous E^CRE complex as
well included p300, since it was a¡ected by the p300 mono-
clonal antibodies Rw144 and AC238 in both cell lines; the
CBP antiserum had no e¡ect (Fig. 3A,B). Similarly to the
p300/bHLH complex in myogenic C2C12 cells [18], the E^
CRE complex was not supershifted by the Rw128 monoclonal
antibody, likely because the p300 epitope is not exposed.
3.4. Role of HEB, MASH1 and p300 in vgf transcription
HEB binds an E-box involved in transcriptional inhibition
in non-neuronal cells [13]. To determine whether it had a
repression function on vgf, NIH3T3 ¢broblasts were trans-
fected with the 3179vgfCAT reporter (Fig. 4A) and increasing
amounts of the HEB expression vector. Although vgf is tran-
scriptionally silent in such cells, a transfected vgf promoter
has some transcriptionally activity, due to its high copy num-
ber [11]. Vgf transcription was inhibited by HEB in a dose-
dependent manner (Fig. 4B). To show that the E-box was
implicated in repression, the expression vector was cotrans-
fected with 4ECvgfCAT (Fig. 4A), harboring four repetitions
Fig. 2. MASH1 is required for C complex formation. A: GST-vbHEB inhibited C complex DNA binding. Gel shift assays in the presence of
increasing amounts (100^500 ng) of GST-vbHEB (lanes 2^5) or GST protein (lanes 6^9). E^CRE complex and C complex are indicated.
B: MASH1 antibodies prevent C complex formation.
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of E-box and CCAAT, upstream of an alkaline phosphatase
minimal promoter. Transcription was still inhibited (Fig. 4B).
The E-box weakly promotes vgf transcription in PC12 cells
[13]. Consistently with this observation, vgf transcription was
weakly up-regulated by HEB overexpression in this cell line
(Fig. 5A). Activation by HEB was more evident following
NGF treatment, suggesting that NGF turns on a HEB cofac-
tor such as, for instance, MASH1, up-regulated by NGF and
able to heterodimerize with HEB [17,19]. MASH1 was in-
volved in the complex bound to the CCAAT site (Fig. 2B),
Fig. 4. Vgf transcription is repressed by HEB in ¢broblasts. A: Organization of 3179vgfCAT and 4ECvgfCAT reporter plasmids. The nucleo-
tide sequences are relative to E-box, CCAAT and CRE sites. B: CAT assays of NIH3T3 cells transfected with 3179vgf or 4ECvgf CAT report-
ers and either empty vector (^) or pCSHEB. The relative amounts (0.5U ; 1U) of HEB expression vector compared to the reporter are indi-
cated. Unlike vgf transcription, RSV promoter driven transcription (pRSVCAT plasmid) was not repressed by HEB (not shown). C: HEB
expression in control or pCSHEB-transfected NIH3T3 cells (Western blot).
Fig. 3. p300 binds the vgf promoter. EMSA on PC12 (A) or NIH3T3 (B) cell nuclear extracts. E^CRE and C complexes are indicated by ar-
rows. The ¢rst lane in each panel shows the pattern with extract alone; for the other lanes, the indicated antibodies were added. The E^CRE
complex was supershifted by the two p300 monoclonals AC238 and Rw144, and by the HEB serum. The C complex was a¡ected by all p300
antibodies (AC238, Rw144 and Rw128).
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necessary for activation by NGF [10]. Accordingly, its over-
expression activated vgf transcription in PC12 cells (Fig. 5B);
it is unclear whether MASH1/HEB heterodimers have a role.
As overexpression of p300, a very abundant protein, might
not be very informative, its role in vgf transcription was an-
alyzed by inhibition with a mutant E1A adenoviral protein.
The wild-type E1A protein interacts with both p300 and the
pocket (pRb family) proteins, interfering with gene expression
[21,22]. To speci¢cally target p300 we resorted to dl922^947, a
mutant deleted in CR2, the pocket protein interaction region.
E1A mutant transfection inhibited vgf transcription in PC12
cells, in agreement with the observation that p300 is present in
the C complex, involved in transcriptional control (Fig. 6A).
E1A interacting proteins, most likely p300, are known to be
required for di¡erentiation in response to NGF [21] : we used
the dl922^947 mutant to more speci¢cally assay for a role of
p300. Following transfection with the mutant and a L-gal
expression plasmid, PC12 cells were induced to di¡erentiate
with NGF. A dose-dependent inhibition of neurite outgrowth
was caused by the E1A mutant in transfected cells, identi¢ed
by L-gal staining, showing that p300 is needed for di¡erentia-
tion (Fig. 6B).
4. Discussion
Vgf neural speci¢city and neurotrophin responsiveness were
shown to be linked to two promoter bound complexes, E^
CRE and C. Transcription in non-neuronal cells was inhibited
by a component of the E^CRE complex, HEB, while neuro-
trophin signalling targeted the CCAAT bound complex,
which included CREB. The p300 histone acetyl transferase
[23^25] was required for vgf transcription and, as previously
suggested [21], for neurite extension in response to NGF. The
presence of this coactivator in two complexes with opposite
roles in vgf transcription might be explained if its functions
were di¡erentially modulated by MASH1 and HEB, bHLH
proteins present in C and E^CRE complex, respectively. This
is conceivable, since p300 activity in other systems was shown
to be stimulated by the tissue-speci¢c bHLH MyoD, and to be
suppressed by another bHLH, Twist [14,18,25]. Moreover, a
transcriptional repression domain was found to be present
within p300 [26]. A negative regulation of p300 by HEB,
although not directly proven, would be compatible with the
¢ndings that HEB and p300 concurred to the E^CRE com-
plex and that HEB repressed the promoter in ¢broblasts (Fig.
4). It would also explain why cAMP is unable to stimulate vgf
transcription in non-neuronal cells [27], CRE binding factors
requiring the coactivator [7,24]. A repressive role of HEB is
consistent with the observations that HEB binds the
CAGGTG E-box, which restrains vgf expression in non-neu-
ronal cells, that E-boxes with the same sequence inhibit
GATA-3 gene promoter in non-T-cells, and that p75NTR
gene transcription is inhibited by HEB [13,28,29]. Since
HEB is present at high levels in the developing nervous sys-
Fig. 5. Vgf transcription is activated by HEB and MASH1 in PC12 cells. CAT assays of PC12 cells transfected with 3179vgfCAT and either
empty vector (^) or increasing amounts of HEB (A) and MASH1 (B) expression vectors, in the presence or absence of NGF. The relative
amounts of expression vectors compared to reporter plasmid are shown.
Fig. 6. Vgf transcription (A) and neurite outgrowth (B) are inhibited by an E1A mutant protein that selectively binds p300. A: CAT activities
of PC12 cells transfected with 3179vgfCAT (0.5 Wg) and E1A12S mutant dl922^947 expression vector (0.1 Wg), and treated with NGF. B: Inhi-
bition of neurite outgrowth in PC12 cells transfected with pRSV-Lgal (1 Wg) and increasing amounts (0.2, 0.5 and 1 Wg) of E1A dl922^947 ex-
pression vector.
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tem, before overt di¡erentiation [19,30], it might function to
repress neuro-speci¢c genes during early stages of develop-
ment. The vgf promoter is no longer silent in neuronal cells,
where it is ready to be activated by neurotrophins. This is
re£ected by the replacement of an inhibitory E^CRE complex
with an activating C complex, which involves CREB, p300
and MASH1. According to our model, the neuro-speci¢c
bHLH facilitates chromatin modi¢cations by p300, making
the promoter competent for activation by neurotrophin sig-
nalling, which impinges on CREB (Fig. 7). It may appear
surprising that a sequence di¡erent from their canonical
DNA targets is so relevant for vgf transcriptional activation
by CREB and MASH1. It should be considered that we are
dealing with a large complex, to which they could be recruited
via protein^protein interactions. As a matter of fact it was
already reported that both CREB and HLH transcription
factors are able to regulate cell type-speci¢c gene transcription
in a manner that may not require direct binding to their
preferred DNA recognition sequence [14,31].
None of the proteins that were shown to be involved in the
C complex speci¢cally binds the CCAAT sequence, indicating
that the complex must include at least another factor that
speci¢cally recognizes this site. A candidate is the NF-Y het-
eromeric protein, the major CCAAT recognizing factor in
vertebrate cells, which was shown to interact with p300 [32].
In conclusion, the neurotrophin-dependent expression of
vgf appears to be achieved by the synergy of di¡erent factors
(bHLHs, CREB, p300 and others) present in a large complex
that binds the promoter and is target of NGF signalling. The
interaction of di¡erent proteins on a target gene promoter can
function to confer speci¢city to neurotrophin signalling, via
the interaction between CREB and a neuro-speci¢c bHLH
protein, and to integrate di¡erent cues that bear upon distinct
transcription factors. It remains to be investigated whether the
bHLH^p300^CREB interaction is peculiar to vgf or it repre-
sents a more general mechanism for gene regulation by neuro-
trophins and for conferring neural speci¢city to CREB-medi-
ated transcription.
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